Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
10/2000
10/05/2000WO2000027421A3 LOCAL USE OF SOLUBLE TUMOR NECROSIS RECEPTOR I (sTNFRI) FOR PROPHYLAXIS AND TREATMENT OF CORNEAL TRANSPLANT REJECTION AND OTHER DISORDERS OF THE EYE
10/05/2000WO2000011167A3 Nucleic acids encoding a functional human purinoreceptor p2x2 and methods of producing and use thereof
10/05/2000CA2383592A1 2384891 acids including open reading frames encoding polypeptides; orfx
10/05/2000CA2368951A1 50 human secreted proteins
10/05/2000CA2368881A1 50 human secreted proteins
10/05/2000CA2368719A1 50 human secreted proteins
10/05/2000CA2368700A1 49 human secreted proteins
10/05/2000CA2368631A1 Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof
10/05/2000CA2368489A1 50 human secreted proteins
10/05/2000CA2368467A1 50 human secreted proteins
10/05/2000CA2368374A1 47 human secreted proteins
10/05/2000CA2368302A1 49 human secreted proteins
10/05/2000CA2368281A1 50 human secreted proteins
10/05/2000CA2368090A1 Compounds and methods for treatment of asthma, allergy and inflammatory disorders
10/05/2000CA2366305A1 Method for expressing proteins
10/05/2000CA2365401A1 Aryl fused 2,4-disubstituted pyridines: nk3 receptor ligands
10/04/2000EP1041072A1 Dioxocyclopentyl hydroxamic acids
10/04/2000EP1041068A1 Compounds for treating and preventing diabetic complications
10/04/2000EP1040838A1 Stable aqueous EM 12 solution
10/04/2000EP1040837A2 Medicaments for the treatment of a choroidal neovascularization (CNV) related disorder
10/04/2000EP1040111A1 Integrin receptor antagonists
10/04/2000EP1040100A1 Therapeutically active compounds based on indazole bioisostere replacement of catechol in pde4 inhibitors
10/04/2000EP1040099A1 Azepine or larger medium ring derivatives and their use as pharmaceuticals
10/04/2000EP1040098A1 Integrin receptor antagonists
10/04/2000EP1039929A1 Activated t-cells and their uses
10/04/2000EP1039912A1 Angiostatic agents and compositions for controlling ocular hypertension
10/04/2000EP1039904A1 Synergistic antimicrobial compositions
10/04/2000EP1039895A1 Use of 3-benzoyl-phenylacetic acids, esters, or amides for treatment of glc1a glaucoma
10/04/2000EP0772610B1 Dihydrobenzofuranes
10/04/2000EP0766672B1 Arylsulfonamido-substituted hydroxamic acids as matrix metalloproteinase inhibitors
10/04/2000EP0664705B1 Compositions of ergoline derivatives for the treatment of glaucoma
10/04/2000CN1056979C Smelling medicine for improving vision and the bag and container for the medicine
10/03/2000US6127681 Scanning tunnel microscope
10/03/2000US6127542 Chemical intermediates to specified pyrazino(2',1':6,1)pyrido(3,4b)indole-1,4-diones which are selective inhibitors of cyclic guanosine 3',5'-monophosphate specific phosphodiesterase; to treat cardiovascular disorders
10/03/2000US6127401 Treatment of prostate disorders, angiogenic disorders, neoplasia, rheumatoid arthritis, pulmonary fibrosis, myelofibrosis, abnormal wound healing, atherosclerosis, or restenosis, alzheimer's disease
10/03/2000US6127389 Benzimidazole derivatives as bradykinin agonists
10/03/2000US6127382 An antiproliferative agent for treating skin-related diseases, an antitumor agent treating cancer, an antiinflammatory agent treating pulmonary fibrosis, ileitis, colitis and krohn's disease
10/03/2000US6127367 Administering an aldose reductase inhibitor as an antiischemic agent
10/03/2000US6126957 Ticrynafen or indacrinone in an amount effective to lower interocular pressure
10/03/2000US6126939 Anti-inflammatory dipeptide and pharmaceutical composition thereof
09/2000
09/30/2000CA2302886A1 A stable aqueous solution of em 12
09/28/2000WO2000056910A1 Retroviral vectors comprising functional and non-functional splice donor and splice acceptor sites
09/28/2000WO2000056882A1 48 human secreted proteins
09/28/2000WO2000056862A1 Human tumor necrosis factor receptor tr9
09/28/2000WO2000056772A1 Human antibodies that bind human il-12 and methods for producing
09/28/2000WO2000056767A1 46 human secreted proteins
09/28/2000WO2000056755A1 49 human secreted proteins
09/28/2000WO2000056754A1 48 human secreted proteins
09/28/2000WO2000056751A1 50 human secreted proteins
09/28/2000WO2000056704A1 Hydroxamic and carboxylic acid derivatives
09/28/2000WO2000056360A2 Vaccine against antigens from bacteriae
09/28/2000WO2000056359A2 Vaccine against streptococcus pneumoniae
09/28/2000WO2000056358A2 Vaccine against streptococcus pneumoniae capsular polysaccharides
09/28/2000WO2000056340A1 Method for treating and/or preventing retinal diseases with sustained release corticosteroids
09/28/2000WO2000056304A2 Anti-inflammatory uses of manzamines
09/28/2000WO2000035428A3 Tricyclic nitrogen heterocycles as pde iv inhibitors
09/28/2000WO2000027424B1 Upregulation of endogenous prostaglandins to lower intraocular pressure
09/28/2000WO2000024396A9 Treatment of disorders of the outer retina
09/28/2000WO2000022143A3 Protein kinase homologs
09/28/2000WO2000015793A3 Human gpcr proteins
09/28/2000WO2000003741A3 Methods for reducing intraocular pressure using a3-adenosine antagonists
09/28/2000CA2669512A1 Human antibodies that bind human il-12 and methods for producing
09/28/2000CA2368210A1 50 human secreted proteins
09/28/2000CA2367963A1 Hydroxamic and carboxylic acid derivatives
09/28/2000CA2367488A1 Retroviral vectors comprising functional and non-functional splice donor and splice acceptor sites
09/28/2000CA2366691A1 48 human secreted proteins
09/28/2000CA2366152A1 Streptococcus pneumoniae vaccine
09/28/2000CA2366132A1 48 human secreted proteins
09/28/2000CA2365296A1 Vaccine
09/28/2000CA2365255A1 Human tumor necrosis factor receptor tr9
09/28/2000CA2365247A1 49 human secreted proteins
09/28/2000CA2365223A1 46 human secreted proteins
09/27/2000EP1038011A2 Methods of producing anti-angiogenic proteins; endostatin, angiostatin or restin, using a pichia yeast expression system
09/27/2000EP1037985A1 Restin and methods of use thereof
09/27/2000EP1037983A1 Mutants of endostatin, "em 1" having anti-angiogenic activity and methods of use thereof
09/27/2000EP1037981A1 Soluble inhibitors of vascular endothelial growth factor and use thereof
09/27/2000EP1037887A1 5-(2-imidazolinylamino)-benzimidazole derivatives, their preparation and their use as .alpha.-adrenoceptor agonists with improved metabolic stability
09/27/2000EP1037886A1 Triazine angiogenesis inhibitors
09/27/2000EP1037661A1 ribH
09/27/2000EP1037660A1 ribB
09/27/2000EP1037654A1 ribA
09/27/2000EP1037627A1 Use of 11-(3-dimethylaminopropylidene)-6,11-dihydrodibenz[b,e]oxepin-2-acetic acid and of pharmaceutically acceptable salts thereof for the manufacture of a medicament for the treatment of non-allergic ophthalmic inflammatory disorders and for the prevention of ocular neovascularization
09/27/2000EP1037622A1 Taurine derivatives usable in the treatment of ophthalmic disorders
09/27/2000EP1037620A1 Use of formoterol in medicament for inflammation/allergy in upper airways
09/27/2000CN1268122A Branched alkoxy- substituted 2-aminopyridines as NOS inhibitors
09/27/2000CN1268112A Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives
09/27/2000CN1267525A Nutritious eye-protecting health powder for middle aged and old people
09/27/2000CN1056756C Vision recovery capsule
09/26/2000US6124344 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
09/26/2000US6124332 Metalloproteinase inhibitors
09/26/2000US6124329 Metalloproteinase inhibitors
09/26/2000US6124312 Heterocyclic compounds
09/26/2000US6124296 Arylglycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds
09/26/2000US6124288 Phosphodiesterase iv inhibitors
09/26/2000US6124119 Nucleotide sequences coding enzymatic polypeptide; for the treatment and prevention of bacterial infection; bactericides
09/26/2000US6124037 Surgical instrument with coating of polymerizable monomer such as (per)fluoroalkyl ether-substituted hydroxymethacrylic acid and its esters and amides, including ethoxylated, alkyl ammonium, and polyol substituents; coated ophthalmic device
09/26/2000US6123938 Human urinary hyaluronidase
09/21/2000WO2000055371A1 27 human secreted proteins
09/21/2000WO2000055352A2 50 human secreted proteins
09/21/2000WO2000055351A1 Human colon cancer associated gene sequences and polypeptides
1 ... 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 ... 531